Remove FDA Remove Pharmaceutical manufacturing Remove Physicians Remove Retail
article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. 3) policing anticompetitive settlements between competing drug manufacturers.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We We promptly discussed this need with the FDA and the agency agreed to a proposed amendment of the protocol to accommodate, in a safe manner, the patient access to the EAP.”.